Currently out of the existing stock ratings of Luca Issi, 47 are a HOLD (38.84%), 73 are a BUY (60.33%), 1 are a SELL (0.83%).

Luca Issi

Work Performance Price Targets & Ratings Chart

Analyst Luca Issi works at RBC with a stock forecast success ratio of 35.15% fulfilled within 92.57 days on average.

Luca Issi’s has documented 239 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRNA, Moderna at 03-May-2024.

Wall Street Analyst Luca Issi

Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 1/29/2024. The price target of $25 was fulfilled within 7 days with a profit of $6.98 (38.73%) receiving and performance score of 55.34.

Average potential price target upside

ALLO Allogene Therapeutics ALNY Alnylam Pharmaceuticals ARWR Arrowhead Pharmaceuticals BLUE Bluebird bio CRSP Crispr Therapeutics AG DRNA Dicerna Pharmaceuticals IONS Ionis Pharmaceuticals RGNX Regenxbio WVE Wave Life Sciences Ltd SGMO Sangamo Therapeutics ADVM Adverum Biotechnologies CRBU Caribou Biosciences EDIT Editas Medicine FIXX Homology Medicines NTLA Intellia Therapeutics GRPH Graphite Bio VERV Verve Therapeutics MRNA Moderna MGTX MeiraGTx Holdings PLC BEAM Beam Therapeutics  BMRN Biomarin Pharmaceutical QURE Uniqure NV FDMT 4D Molecular Therapeutics 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$6.48 (257.14%)

10

10 days ago

0/6 (0%)

$5.99 (199.00%)

Buy

17

$14.48 (574.60%)

11 days ago

2/10 (20%)

$14.02 (470.47%)

94

Hold

4.6

$2.08 (82.54%)

5

12 days ago

3/8 (37.5%)

$1.64 (55.41%)

11

Buy

8

$5.48 (217.46%)

9

2 months 29 days ago

0/3 (0%)

$2.86 (55.64%)

Buy

10

$7.48 (296.83%)

12

4 months 7 days ago

1/7 (14.29%)

$6.91 (223.62%)

28

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Luca Issi is most bullish on?

Potential upside of $87.24 has been obtained for ALNY (ALNYLAM PHARMACEUTICALS)

Which stock is Luca Issi is most reserved on?

Potential downside of -$31.61 has been obtained for MRNA (MODERNA)

What Year was the first public recommendation made by Luca Issi?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?